Diabetes Mellitus, Type 2 Author: Sandeep Vijan, MD
Editorial changes - 2010-03-01
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Quality Measures Quality Measures
Frequently Asked Questions
Screening
Whom should be screened for diabetes?
When should patients be screened for diabetes?
What is the best way to screen for diabetes?
Diagnosis
What are the latest laboratory criteria for making the diagnosis of diabetes?
What elements of history and physical examination are important in looking for complications of diabetes?
What baseline laboratory tests are essential to obtain in patients with suspected diabetes?
With what other disease processes is glucose intolerance associated?
Consultation for Diagnosis
How should patients with fasting blood glucose levels be managed if they do not meet the criteria for making the diagnosis of diabetes?
What are some of the more unusual causes of diabetes?
What are the criteria for making the diagnosis of gestational diabetes?
Hospitalization
Is there a role for hospitalization for patients in whom glycemic control cannot be achieved in the outpatient setting?
Non-drug Therapy
What lifestyle modifications are necessary for all patients with diabetes?
When and how often is home glucose monitoring necessary?
What are the current dietary recommendations for patients with diabetes?
Drug Therapy
What factors influence initial choice of a hypoglycemia agent in patients with newly diagnosed type 2 diabetes?
What is the target level of hemoglobin A1C in patients undergoing treatment for diabetes?
What are the criteria for beginning an angiotensin converting enzyme inhibitor in patients with diabetes?
What drug should be used for hypertension in patients with diabetes who cannot tolerate angiotensin converting enzyme inhibitors?
What is the effect of specific hypoglycemia agents on weight in patients with diabetes?
What are the side effects of the newer thiozoladinediones?
What is the best way to combine insulin and oral hypoglycemics in patients with diabetes?
What is the best drug for neuropathic pain?
Patient Education
What are the best patient education resources for patients with diabetes?
What is the benefit of counseling patients about diet and lifestyle factors that affect diabetes?
What advice do I offer patients with diabetes in order to prevent foot complications?
Consultation for Management
When should patients with poor control despite multi-drug therapy be referred to an endocrinologist?
What specialists should be involved in the care of diabetes patients on an ongoing basis?
Follow-up
How often should patients with type 2 diabetes be evaluated in the office?
What are the key elements of follow-up for patients with diabetes?
What tests are necessary in following patients with diabetes and how often should they be done?
| Patient Information
Sandeep Vijan, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for continuing medical education grand rounds and lectures given.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.